Skip to main content
Caplight Logo









Heuron

Heuron

Private
SeoulHealthcare & Life Scienceshttps://iheuron.com/

Last Round

Series D

Dec 1, 2024

Est. Valuation

$178.23M

Total Funding Raised

$32.14M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Heuron is a healthcare technology company that provides AI-based diagnostic aid solutions for central nervous system diseases, including Alzheimer's, Parkinson's, and stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Computer Vision, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AImedical imaging softwarediagnostic support softwareradiology AIneurology AIintracranial hemorrhage detectionstroke triageneurodegenerative disease diagnosisclinical workflow automationcomputer visionmedical device softwaremedtechai diagnosticsdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Heuron Comparables

Compare Heuron with similar companies based on industry and business-model similarity.

Heuron comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brainomix
86%
JLK Inc.
84%
RapidAI
83%

Heuron Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DDec 1, 2024
Series CMay 1, 2021
Series BJul 22, 2020
Series AJul 4, 2019

Key People

Founding team and executive leadership

Donghoon Shin

Chief Executive Officer

Executive Team

Soohwa Song

Chief Technology Officer

Executive Team

Heuron Investors

Notable investors and investment history

Heuron investors
InvestorRounds
Smilegate InvestmentSeries B
Korea Investment PartnersSeries B
LogInvestmentSeries C
Korea Growth Investment CorporationSeries C
HB InvestmentSeries C, Series B, Series D
We VenturesSeries B
Korea Investment & SecuritiesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 186% MoM.

  • Apr 17, 2025

    Attended the 2025 Korean Emergency Medicine Academic Conference in Gwangju.

Heuron Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Heuron Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Heuron's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range33
Year Founded2017
Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?